Page 3 - American Amdocs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amdocs Limited of Class Action Lawsuit and Upcoming Deadline – DOX April 23, 2021 23:47 ET | Source: Pomerantz LLP Pomerantz LLP New York, New York, UNITED STATES NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amdocs Limited (“Amdocs” or the “Company”) (NASDAQ: DOX), and certain of its officers. The class action, filed in the United States District Court for the Central Di...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Multiplan Corporation, Ebang, 3D Systems, and Amdocs and Encourages Investors to Contact the Firm April 21, 2021 20:00 ET | Source: Bragar Eagel & Squire Bragar Eagel & Squire New York, New York, UNITED STATES NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of MultiPlan Corporation (NYSE: MPLN...

Search jobs 06-Apr-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amdocs Limited (DOX) on Behalf of Investors LOS ANGELES--(BUSINESS WIRE)--$DOX#CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Amdocs Limited (“Amdocs” or the “Company”) (NASDAQ: DOX) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Amd...

Share this article Share this article MILWAUKEE, April 1, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Amdocs, Ltd. (NASDAQ: DOX).  The investigation results from inaccurate statements Amdocs may have made regarding its financial results, business operations and prospects. Click here to learn more about the investigation: https://www.ademilaw.com/case/amdocs-ltd or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. The investigation focuses on whether Amdocs properly disclosed its financial results. A March 31 report...